# Study of ONO-8577 in Patients With Overactive Bladder

> **NCT03106623** · PHASE2 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 207 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** ONO-8577
- **DRUG:** solifenacin succinate + mirabegron
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03106623
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-07
- **Primary completion:** 2017-08-29
- **Final completion:** 2017-09-26
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03106623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03106623, "Study of ONO-8577 in Patients With Overactive Bladder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03106623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*